HURA — TuHURA Biosciences Share News
0.000.00%
Last trade - 00:00- $131.28m
- $134.16m
Brief: Kintara Therapeutics Awarded $2 Mln National Institutes Of Health SBIR Grant To Support Clinical Development Of REM-001
Kintara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Kintara Therapeutics Announces Q3 Results
Kintara Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Kintara Therapeutics Announces Fiscal 2023 Second Quarter Results
Kintara Therapeutics Inc expected to post a loss of $3.16 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Trip.com, Verizon Communications, Netflix
Kintara rises as FDA grants orphan drug tag to its brain cancer drug
Brief: Kintara Therapeutics Receives FDA's 'Orphan Drug' Status For Val-083 For Treatment Of Diffuse Intrinsic Pontine Glioma
Brief: Kintara Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-Talkspace, Flora Growth, Grindr Inc
U.S. STOCKS ON THE MOVE-Builders FirstSource, Tenaya Therapeutics, Blue Apron
U.S. STOCKS ON THE MOVE-Taboola, Axsome, Amazon
Kintara up as FDA grants fast track designation to its breast cancer drug
Brief: Kintara Therapeutics Granted Fast Track Designation From FDA For Rem-001 For Cutaneous Metastatic Breast Cancer
Kintara Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-UnitedHealth, Lifestyle, Exxon
U.S. STOCKS ON THE MOVE-LegalZoom, Snail, metal miners
Kintara Therapeutics hits record low on reverse stock-split plan